Auto - Dealerships
Compare Stocks
5 / 10Stock Comparison
DRVN vs MNRO vs DORM vs MUSA vs PTEN
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
Auto - Parts
Specialty Retail
Oil & Gas Drilling
DRVN vs MNRO vs DORM vs MUSA vs PTEN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Auto - Dealerships | Auto - Parts | Auto - Parts | Specialty Retail | Oil & Gas Drilling |
| Market Cap | $2.26B | $523M | $3.72B | $10.75B | $4.33B |
| Revenue (TTM) | $2.17B | $1.18B | $2.15B | $19.68B | $4.66B |
| Net Income (TTM) | $-198M | $-13M | $190M | $554M | $-119M |
| Gross Margin | 52.1% | 34.8% | 40.7% | 5.5% | 8.8% |
| Operating Margin | -7.3% | 2.3% | 15.6% | 4.3% | -1.6% |
| Forward P/E | 10.9x | 32.4x | 15.0x | 19.8x | — |
| Total Debt | $4.00B | $529M | $633M | $3.25B | $1.28B |
| Cash & Equiv. | $170M | $21M | $49M | $29M | $421M |
DRVN vs MNRO vs DORM vs MUSA vs PTEN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Driven Brands Holdi… (DRVN) | 100 | 48.9 | -51.1% |
| Monro, Inc. (MNRO) | 100 | 29.8 | -70.2% |
| Dorman Products, In… (DORM) | 100 | 137.1 | +37.1% |
| Murphy USA Inc. (MUSA) | 100 | 466.6 | +366.6% |
| Patterson-UTI Energ… (PTEN) | 100 | 185.5 | +85.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DRVN vs MNRO vs DORM vs MUSA vs PTEN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DRVN ranks third and is worth considering specifically for growth exposure.
- Rev growth 1.5%, EPS growth 59.8%, 3Y rev CAGR 16.8%
- Better valuation composite
MNRO is the clearest fit if your priority is dividends.
- 6.4% yield, 1-year raise streak, vs MUSA's 0.4%, (2 stocks pay no dividend)
DORM has the current edge in this matchup, primarily because of its strength in valuation efficiency.
- PEG 1.00 vs MUSA's 1.53
- 6.0% revenue growth vs PTEN's -10.3%
- 8.8% margin vs DRVN's -9.1%
MUSA is the clearest fit if your priority is long-term compounding.
- 8.0% 10Y total return vs DORM's 129.7%
- 11.7% ROA vs DRVN's -4.2%, ROIC 15.8% vs -2.2%
PTEN is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 0.59, yield 2.8%
- Lower volatility, beta 0.59, Low D/E 39.7%, current ratio 1.64x
- Beta 0.59, yield 2.8%, current ratio 1.64x
- Beta 0.59 vs MNRO's 1.50, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.0% revenue growth vs PTEN's -10.3% | |
| Value | Better valuation composite | |
| Quality / Margins | 8.8% margin vs DRVN's -9.1% | |
| Stability / Safety | Beta 0.59 vs MNRO's 1.50, lower leverage | |
| Dividends | 6.4% yield, 1-year raise streak, vs MUSA's 0.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +111.0% vs DRVN's -24.6% | |
| Efficiency (ROA) | 11.7% ROA vs DRVN's -4.2%, ROIC 15.8% vs -2.2% |
DRVN vs MNRO vs DORM vs MUSA vs PTEN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DRVN vs MNRO vs DORM vs MUSA vs PTEN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MUSA leads in 3 of 6 categories
MNRO leads 1 • DRVN leads 0 • DORM leads 0 • PTEN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — DRVN and DORM each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MUSA is the larger business by revenue, generating $19.7B annually — 16.7x MNRO's $1.2B. DORM is the more profitable business, keeping 8.8% of every revenue dollar as net income compared to DRVN's -9.1%. On growth, MUSA holds the edge at +6.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $1.2B | $2.2B | $19.7B | $4.7B |
| EBITDAEarnings before interest/tax | $17M | $90M | $377M | $1.1B | $851M |
| Net IncomeAfter-tax profit | -$198M | -$13M | $190M | $554M | -$119M |
| Free Cash FlowCash after capex | $41M | $50M | $71M | $555M | $273M |
| Gross MarginGross profit ÷ Revenue | +52.1% | +34.8% | +40.7% | +5.5% | +8.8% |
| Operating MarginEBIT ÷ Revenue | -7.3% | +2.3% | +15.6% | +4.3% | -1.6% |
| Net MarginNet income ÷ Revenue | -9.1% | -1.1% | +8.8% | +2.8% | -2.6% |
| FCF MarginFCF ÷ Revenue | +1.9% | +4.2% | +3.3% | +2.8% | +5.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.5% | -4.0% | +4.2% | +6.5% | -12.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +5.1% | +150.0% | -23.5% | +176.8% | — |
Valuation Metrics
MNRO leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 18.8x trailing earnings, DORM trades at a 22% valuation discount to MUSA's 24.1x P/E. Adjusting for growth (PEG ratio), DORM offers better value at 1.25x vs MUSA's 1.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.3B | $523M | $3.7B | $10.8B | $4.3B |
| Enterprise ValueMkt cap + debt − cash | $6.1B | $1.0B | $4.3B | $14.0B | $5.2B |
| Trailing P/EPrice ÷ TTM EPS | -7.55x | -79.23x | 18.75x | 24.12x | -47.54x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.90x | 32.40x | 15.05x | 19.84x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.25x | 1.85x | — |
| EV / EBITDAEnterprise value multiple | 126.43x | 9.41x | 10.41x | 13.71x | 5.67x |
| Price / SalesMarket cap ÷ Revenue | 0.97x | 0.44x | 1.75x | 0.55x | 0.90x |
| Price / BookPrice ÷ Book value/share | 3.63x | 0.84x | 2.59x | 18.20x | 1.36x |
| Price / FCFMarket cap ÷ FCF | — | 4.96x | 49.18x | 28.73x | 11.64x |
Profitability & Efficiency
MUSA leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MUSA delivers a 89.5% return on equity — every $100 of shareholder capital generates $90 in annual profit, vs $-28 for DRVN. PTEN carries lower financial leverage with a 0.40x debt-to-equity ratio, signaling a more conservative balance sheet compared to DRVN's 6.58x. On the Piotroski fundamental quality scale (0–9), DORM scores 7/9 vs MNRO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -28.4% | -2.1% | +13.1% | +89.5% | -3.7% |
| ROA (TTM)Return on assets | -4.2% | -0.8% | +7.6% | +11.7% | -2.2% |
| ROICReturn on invested capital | -2.2% | +2.5% | +13.9% | +15.8% | -0.4% |
| ROCEReturn on capital employed | -2.7% | +3.4% | +18.5% | +20.0% | -0.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 7 | 5 | 5 |
| Debt / EquityFinancial leverage | 6.58x | 0.85x | 0.43x | 5.22x | 0.40x |
| Net DebtTotal debt minus cash | $3.8B | $509M | $584M | $3.2B | $860M |
| Cash & Equiv.Liquid assets | $170M | $21M | $49M | $29M | $421M |
| Total DebtShort + long-term debt | $4.0B | $529M | $633M | $3.3B | $1.3B |
| Interest CoverageEBIT ÷ Interest expense | -1.23x | 0.09x | 8.24x | 7.47x | -0.96x |
Total Returns (Dividends Reinvested)
MUSA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MUSA five years ago would be worth $41,821 today (with dividends reinvested), compared to $3,236 for MNRO. Over the past 12 months, PTEN leads with a +111.0% total return vs DRVN's -24.6%. The 3-year compound annual growth rate (CAGR) favors MUSA at 27.2% vs MNRO's -24.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.2% | -10.1% | +0.3% | +43.5% | +77.9% |
| 1-Year ReturnPast 12 months | -24.6% | +45.4% | +0.5% | +15.3% | +111.0% |
| 3-Year ReturnCumulative with dividends | -51.1% | -57.7% | +41.6% | +106.0% | +17.3% |
| 5-Year ReturnCumulative with dividends | -51.1% | -67.6% | +19.2% | +318.2% | +48.7% |
| 10-Year ReturnCumulative with dividends | -48.5% | -62.4% | +129.7% | +803.3% | -22.1% |
| CAGR (3Y)Annualised 3-year return | -21.2% | -24.9% | +12.3% | +27.2% | +5.5% |
Risk & Volatility
MUSA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MUSA is the less volatile stock with a -0.23 beta — it tends to amplify market swings less than MNRO's 1.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MUSA currently trades 95.3% from its 52-week high vs DRVN's 69.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.68x | 1.50x | 0.85x | -0.23x | 0.59x |
| 52-Week HighHighest price in past year | $19.74 | $23.91 | $166.89 | $609.82 | $12.62 |
| 52-Week LowLowest price in past year | $9.80 | $12.20 | $98.44 | $345.23 | $5.10 |
| % of 52W HighCurrent price vs 52-week peak | +69.7% | +72.9% | +74.6% | +95.3% | +90.4% |
| RSI (14)Momentum oscillator 0–100 | 54.3 | 55.4 | 71.2 | 64.0 | 55.4 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 770K | 273K | 354K | 10.6M |
Analyst Outlook
Evenly matched — MNRO and MUSA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DRVN as "Buy", MNRO as "Hold", DORM as "Buy", MUSA as "Hold", PTEN as "Buy". Consensus price targets imply 129.5% upside for MNRO (target: $40) vs -13.2% for MUSA (target: $504). For income investors, MNRO offers the higher dividend yield at 6.43% vs MUSA's 0.37%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $18.00 | $40.00 | $140.00 | $504.25 | $11.00 |
| # AnalystsCovering analysts | 15 | 24 | 16 | 11 | 53 |
| Dividend YieldAnnual dividend ÷ price | — | +6.4% | — | +0.4% | +2.8% |
| Dividend StreakConsecutive years of raises | 2 | 1 | 2 | 5 | 1 |
| Dividend / ShareAnnual DPS | — | $1.12 | — | $2.13 | $0.32 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% | +1.1% | +6.0% | +1.6% |
MUSA leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). MNRO leads in 1 (Valuation Metrics). 2 tied.
DRVN vs MNRO vs DORM vs MUSA vs PTEN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DRVN or MNRO or DORM or MUSA or PTEN a better buy right now?
For growth investors, Dorman Products, Inc.
(DORM) is the stronger pick with 6. 0% revenue growth year-over-year, versus -10. 3% for Patterson-UTI Energy, Inc. (PTEN). Dorman Products, Inc. (DORM) offers the better valuation at 18. 8x trailing P/E (15. 0x forward), making it the more compelling value choice. Analysts rate Driven Brands Holdings Inc. (DRVN) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DRVN or MNRO or DORM or MUSA or PTEN?
On trailing P/E, Dorman Products, Inc.
(DORM) is the cheapest at 18. 8x versus Murphy USA Inc. at 24. 1x. On forward P/E, Driven Brands Holdings Inc. is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Dorman Products, Inc. wins at 1. 00x versus Murphy USA Inc. 's 1. 53x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — DRVN or MNRO or DORM or MUSA or PTEN?
Over the past 5 years, Murphy USA Inc.
(MUSA) delivered a total return of +318. 2%, compared to -67. 6% for Monro, Inc. (MNRO). Over 10 years, the gap is even starker: MUSA returned +803. 3% versus MNRO's -62. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DRVN or MNRO or DORM or MUSA or PTEN?
By beta (market sensitivity over 5 years), Murphy USA Inc.
(MUSA) is the lower-risk stock at -0. 23β versus Monro, Inc. 's 1. 50β — meaning MNRO is approximately -748% more volatile than MUSA relative to the S&P 500. On balance sheet safety, Patterson-UTI Energy, Inc. (PTEN) carries a lower debt/equity ratio of 40% versus 7% for Driven Brands Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DRVN or MNRO or DORM or MUSA or PTEN?
By revenue growth (latest reported year), Dorman Products, Inc.
(DORM) is pulling ahead at 6. 0% versus -10. 3% for Patterson-UTI Energy, Inc. (PTEN). On earnings-per-share growth, the picture is similar: Patterson-UTI Energy, Inc. grew EPS 90. 2% year-over-year, compared to -119. 3% for Monro, Inc.. Over a 3-year CAGR, PTEN leads at 22. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DRVN or MNRO or DORM or MUSA or PTEN?
Dorman Products, Inc.
(DORM) is the more profitable company, earning 9. 6% net margin versus -12. 5% for Driven Brands Holdings Inc. — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus -6. 0% for DRVN. At the gross margin level — before operating expenses — DRVN leads at 52. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DRVN or MNRO or DORM or MUSA or PTEN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Dorman Products, Inc. (DORM) is the more undervalued stock at a PEG of 1. 00x versus Murphy USA Inc. 's 1. 53x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Driven Brands Holdings Inc. (DRVN) trades at 10. 9x forward P/E versus 32. 4x for Monro, Inc. — 21. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MNRO: 129. 5% to $40. 00.
08Which pays a better dividend — DRVN or MNRO or DORM or MUSA or PTEN?
In this comparison, MNRO (6.
4% yield), PTEN (2. 8% yield), MUSA (0. 4% yield) pay a dividend. DRVN, DORM do not pay a meaningful dividend and should not be held primarily for income.
09Is DRVN or MNRO or DORM or MUSA or PTEN better for a retirement portfolio?
For long-horizon retirement investors, Murphy USA Inc.
(MUSA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 23), +803. 3% 10Y return). Monro, Inc. (MNRO) carries a higher beta of 1. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MUSA: +803. 3%, MNRO: -62. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DRVN and MNRO and DORM and MUSA and PTEN?
These companies operate in different sectors (DRVN (Consumer Cyclical) and MNRO (Consumer Cyclical) and DORM (Consumer Cyclical) and MUSA (Consumer Cyclical) and PTEN (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DRVN is a small-cap quality compounder stock; MNRO is a small-cap income-oriented stock; DORM is a small-cap quality compounder stock; MUSA is a mid-cap quality compounder stock; PTEN is a small-cap quality compounder stock. MNRO, PTEN pay a dividend while DRVN, DORM, MUSA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.